Avoid excessive heat, moisture, and repeated temperature changes during storage
Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying
Cartilage and osteoarthritis models published research has explored AOD-9604 in articular cartilage and chondrocyte models, sometimes in combination with HA or other matrix peptides
Concentrations available: 2.5 mg/dose 5 mg/dose 7.5 mg/dose 10 mg/dose 12.5 mg/dose 15 mg/dose Standard (Brand-Name) Semaglutide Injectables Standard semaglutide injectables, including Wegovy and Ozempic, offer proven, onceweekly treatment options for effective weight management and blood sugar control
Definitely have seen weight loss as well Ive been using this and the skinny shot off and on for a while now